16 October 2017 Day Trading Pre Market, page-22

OFF TOPIC :

NTI - CR at 20c is not much discount to last traded price and 10 days average - Next few months will only about distribution, trial results and further improvement...Looking good for MT-LT...

Neurotech CEO Wolfgang Storf said: “We are very pleased with the strong response to the placement of new shares from both new and existing investors in the company.

“We are entering what we expect to be a pivotal time for Neurotech and the Mente Autism device. This will include pursuit of further distributorships, completion of the trial as well as ongoing improvements to the Mente Autism device.”